White Amy M, Spies James B
Department of Radiology, Georgetown University Hospital, Washington, DC 20007-2113, USA.
Tech Vasc Interv Radiol. 2006 Mar;9(1):2-6. doi: 10.1053/j.tvir.2006.08.002.
Uterine fibroid embolization (UFE) is a minimally invasive therapy for the treatment of symptomatic uterine fibroids and offers an alternative to conventional myomectomy and hysterectomy. This review focuses on recent publications evaluating UFE and concludes that it is a safe treatment option, providing substantial improvement in both health-related quality of life and symptom control for most patients, with a very low rate of major complications. The durability of these outcomes appears similar to those obtained with myomectomy; however, a direct comparative long-term study is needed. Recent comparative studies have begun to provide more insight in to UFE outcomes compared with outcomes achieved with myomectomy and hysterectomy. UFE should be considered a first line therapy for women with symptomatic uterine fibroids. Additional research will continue to provide us with information as to the ideal candidates for UFE and may provide us with better tools to predict patient outcomes.
子宫纤维瘤栓塞术（UFE）是一种用于治疗有症状子宫纤维瘤的微创疗法，为传统子宫肌瘤切除术和子宫切除术提供了一种替代方案。本综述聚焦于近期评估UFE的出版物，并得出结论：它是一种安全的治疗选择，能使大多数患者的健康相关生活质量和症状控制得到显著改善，且严重并发症发生率极低。这些结果的持久性似乎与子宫肌瘤切除术相似；然而，需要进行直接的长期对比研究。与子宫肌瘤切除术和子宫切除术的结果相比，近期的对比研究已开始更深入地揭示UFE的疗效。对于有症状子宫纤维瘤的女性，UFE应被视为一线治疗方法。更多研究将继续为我们提供关于UFE理想候选者的信息，并可能为我们提供更好的工具来预测患者的治疗结果。
